Scarica l'app Stockscreener
7.77
0.91%
0.07
Nyxoah Sa Borsa (NYXH) Ultime notizie
(NYXH) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Invitation to attend the extraordinary shareholders’ meeting of the Company to be held on July 2, 2025 - Yahoo Finance
Major Governance Shift: Nyxoah Grants Long-term Shareholders New Board Nomination Rights - Stock Titan
Cantor Fitzgerald Forecasts Nyxoah FY2026 Earnings - Defense World
Ameriprise Financial Inc. Takes $135,000 Position in Nyxoah S.A. (NASDAQ:NYXH) - Defense World
When the Price of (NYXH) Talks, People Listen - news.stocktradersdaily.com
Top Premarket Decliners - marketscreener.com
Millennium Management LLC Trims Stock Holdings in Nyxoah S.A. (NASDAQ:NYXH) - Defense World
Nyxoah Announces Change in Shareholder Voting Rights - TipRanks
Vestal Point Capital Cuts Nyxoah Holdings by 40%: Major Ownership Shift Revealed - Stock Titan
Nyxoah to Present at the Jefferies Global Healthcare Conference - The Manila Times
Nyxoah CEO Showcases Revolutionary Sleep Apnea Treatment at Major Jefferies Healthcare Conference - Stock Titan
Nyxoah SA Updates Share Capital and Voting Rights - TipRanks
Information on the total number of voting rights and shares - Yahoo
Head-To-Head Survey: Inspire Medical Systems (NYSE:INSP) versus Nyxoah (NASDAQ:NYXH) - Defense World
Cantor maintains Nyxoah stock Overweight with $14 target By Investing.com - Investing.com Nigeria
Nyxoah Announces CE Mark Approval For Genio® 2.1 - Barchart.com
Cantor maintains Nyxoah stock Overweight with $14 target - Investing.com
Nyxoah SA (NYXH) Reports Q1 Loss, Lags Revenue Estimates - MSN
Trading (NYXH) With Integrated Risk Controls - news.stocktradersdaily.com
Nyxoah Sa’s Earnings Call: Progress Amid Challenges - TipRanks
Nyxoah outlines U.S. Genio launch plan with 50-member team as FDA approval expected Q2 2025 - MSN
Nyxoah S.A. (NASDAQ:NYXH) Q1 2025 Earnings Call Transcript - Insider Monkey
Nyxoah Reports Q1 2025 Financial Results and FDA Progress - TipRanks
Nyxoah Q1 2025 Earnings Call Transcript - MarketBeat
Nyxoah Nears FDA Approval for Genio® System Amid Q1 2025 Results - TipRanks
Nyxoah (NYXH) Nears FDA Approval for Genio System in the U.S. | - GuruFocus
Nyxoah reports Q1 EPS (EUR 0.60) vs. (EUR 0.42) last year - TipRanks
Nyxoah Reports First Quarter Financial and Operating Results - The Manila Times
Nyxoah Nears FDA Approval for Sleep Apnea Device as Q1 Revenue Hits €1.1M | NYXH Stock News - Stock Titan
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Nyxoah S.A. – NYXH - Bluefield Daily Telegraph
Earnings To Watch: Nyxoah SA (NYXH) Reports Q1 2025 Result - GuruFocus
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A.NYXH - PR Newswire
Nyxoah (NYXH) Expected to Announce Quarterly Earnings on Tuesday - Defense World
Publication relating to transparency notifications - Stock Titan
Nyxoah SA Schedules Shareholders’ Meetings for June 2025 - TipRanks
Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 11, 2025 - Yahoo Finance
Nyxoah to Release First Quarter 2025 Financial Results on May 14, 2025 - The Manila Times
REG-Nyxoah to Release First Quarter 2025 Financial Results on May 14, 2025 - TradingView
Renaissance Technologies LLC Purchases Shares of 23,400 Nyxoah S.A. (NASDAQ:NYXH) - Defense World
Long Term Trading Analysis for (NYXH) - news.stocktradersdaily.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Nyxoah S.A.NYXH - Bluefield Daily Telegraph
Nyxoah S.A. (NASDAQ:NYXH) Shares Bought by Geode Capital Management LLC - Defense World
LPL Financial LLC Buys Shares of 12,700 Nyxoah S.A. (NASDAQ:NYXH) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Stifel cuts Nyxoah stock price target to $14, maintains Buy rating - Investing.com Canada
0.32%
0.08%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):